Maximising the cost effectiveness of ractopamine
Share this page via
Production and Welfare
01 September 2011
Completed Project
To determine the optimum dose and timing of paylean application in finishing female pigs and the effect of dietary energy density on paylean responses in finishing pigs.
APL does not condemn or condone the use of ractopamine. The decision to use ractopamine is ultimately a commercial decision for the producer and will be dependent on the markets they supply their pigs into. Some markets both domestically and internationally do not allow use of ractopamine.
Paylean (ractopamine) is known to improve protein deposition and improve the meatiness of carcasses. A clearer definition of the optimal commercial application of Paylean in finishing pigs needs to be determined.
Value for producers:
Recommendations:
For further information on production and welfare, please contact Rebecca Athorn on 0436 655 015 or email: rebecca.athorn@australianpork.com.au